Riskpilot← Back to searchSign inGet full accessStemMedical A/S
A/SBankruptCVR 35852808Gyngemose Parkvej 50Research and experimental development on natural sciences and engineering · NACE 7210Est. 201418 employees
Revenue 2022
DKK -7,9M
+81% vs 2021
EBITDA margin
241.2%
-44% vs 2021
Equity ratio
93.2%
Financial strength
Net profit 2022
DKK -18,9M
-43% vs 2021
| Revenue | DKK -7,9M | +81% |
| EBITDA | DKK -19,1M | -44% |
| Net profit | DKK -18,9M | -43% |
| Total assets | DKK 13,3M | -27% |
| Equity | DKK 12,4M | -24% |
| Employees | 18 | — |
Legal name
StemMedical A/S
CVR number
35852808
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
2. maj 2014
Share capital
DKK 2.106.185
Employees
18 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører i forening, af én direktør i forening med et bestyrelsesmedlem eller af den samlede bestyrelse.
Address
Gyngemose Parkvej 50
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | -80 | -269 | -716 | -1.748 | -1.539 | -2.062 | -3.793 | -4.371 | -7.903 |
| Staff expenses | -121 | -24 | -665 | -411 | -592 | -2.398 | -3.719 | -8.822 | -11.157 |
| EBITDA | -201 | -293 | -1.381 | -1.648 | -2.130 | -4.459 | -7.512 | -13.193 | -19.059 |
| Depreciation & amort. | -13 | -13 | -947 | 255 | -897 | -1.541 | -1.108 | -1.265 | -1.160 |
| EBIT | -214 | -306 | -2.328 | -1.903 | -3.027 | -6.000 | -8.620 | -14.459 | -20.219 |
| Net financials | 0 | 0 | 0 | -1 | -76 | -57 | -92 | -88 | -99 |
| Profit before tax | -214 | -306 | -2.328 | -1.904 | -3.103 | -6.057 | -8.713 | -14.547 | -20.318 |
| Tax | -16 | -0 | -0 | -0 | -713 | -1.974 | -976 | -1.325 | -1.442 |
| Net profit | -198 | -306 | -2.328 | -1.904 | -2.390 | -4.083 | -7.737 | -13.221 | -18.876 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.199 | 1.938 | 7.050 | 5.694 | 8.721 | 7.600 | 31.149 | 18.217 | 13.292 |
| Equity | -104 | 1.897 | 6.807 | 5.403 | 6.265 | 5.546 | 29.606 | 16.385 | 12.393 |
| Long-term debt | 0 | 0 | 0 | 0 | 822 | 256 | 0 | 0 | 0 |
| Short-term debt | 2.303 | 42 | 243 | 291 | 1.634 | 1.798 | 1.542 | 1.832 | 899 |
| Total debt | 2.303 | 42 | 243 | 291 | 2.456 | 2.054 | 1.542 | 1.832 | 899 |
EBITDA margin
-1905939500.0%
This company
15.8%
Market median
-12062908328% vs market
20142022
Equity ratio
93.2%
This company
38.2%
Market median
+144% vs market
20142022
Return on equity
-152.3%
This company
18.4%
Market median
-928% vs market
20142022
Net profit margin
-1887605500.0%
This company
8.1%
Market median
-23303771705% vs market
20142022
Asset turnover
-0.59×
This company
1.12×
Market median
-153% vs market
20142022
Debt / equity
0.07×
This company
0.62×
Market median
+89% vs market
20142022
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
LB Management | Management | 2022 | — | — |
FK Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
PB Management | Management | 2014 | — | — |
KR Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2020 | — | — | |
| Deputy Chairman | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2016 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
FISCHER-NIELSEN HOLDING ApS | Company | 5.0% | 5.0% | 2016 |
| Individual | 10.0% | 10.0% | 2016 | |
D.B. AF 8/1 1996 ApS | Company | 15.0% | 15.0% | 2024 |
PETER SELVIG HOLDING ApS | Company | 10.0% | 10.0% | 2016 |
JULIANA INVEST A/S | Company | 5.0% | 5.0% | 2024 |
SPECIALLÆGE BO JØNSSON ApS | Company | 5.0% | 5.0% | 2024 |
| Individual | 5.0% | 5.0% | 2017 | |
| Individual | 5.0% | 5.0% | 2016 | |
NIS ALSTRUP HOLDING ApS | Company | 5.0% | 5.0% | 2024 |
GITTE POULSEN HOLDING ApS | Company | 5.0% | 5.0% | 2024 |
| Individual | 5.0% | 5.0% | 2018 | |
EVERCARE Ventures ApS | Company | 5.0% | 5.0% | 2024 |
| Individual | 5.0% | 5.0% | 2018 | |
TROJAHN KØLLE HOLDING ApS | Company | 5.0% | 5.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of StemMedical A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lasse Blirup Snejbjerg | Management | 0 companies |
| Frederik Kølle | Chief Executive Officer | 0 companies |
| Peter Bo Selvig | Management | 0 companies |
| Klaus Rudolf Langhoff-Roos | Chief Executive Officer | 0 companies |
| Christina Molt Wengel | Board of Directors | 0 companies |
| Stig Løkke Pedersen | Chairman | 0 companies |
| Christian Nissen Riisberg | Deputy Chairman | 0 companies |
| Erik Aznauryan | Board of Directors | 0 companies |
| Bo Jønsson | Chairman | 0 companies |